Torsin2A Activators

The chemical class of Torsin2A activators encompasses compounds that modulate intracellular signaling pathways involved in cyclic nucleotide regulation and cellular energy homeostasis. These activators can directly or indirectly influence the activation state of Torsin2A, a member of the AAA+ ATPase family implicated in various cellular processes. Rolipram and forskolin, for instance, act as direct activators by increasing intracellular levels of cyclic adenosine monophosphate (cAMP), which is known to stimulate Torsin2A activity. Similarly, isoproterenol and GLP-1 receptor agonists activate adenylate cyclase, leading to elevated cAMP levels and subsequent Torsin2A activation.

Additionally, compounds such as cilostazol and milrinone exert their effects by inhibiting phosphodiesterase enzymes, resulting in the accumulation of cAMP and potential activation of Torsin2A. Other indirect activators include Y-27632, which inhibits Rho-associated protein kinase (ROCK) and modulates cytoskeletal dynamics, potentially influencing Torsin2A activity. Moreover, AICAR activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy metabolism, which may impact Torsin2A function. Collectively, these compounds represent a diverse array of molecules capable of modulating Torsin2A activity through various signaling pathways and cellular processes.